Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus: Results of a multicenter randomized, double-blind, placebo-controlled trial

Michelle A. Petri, Philip J. Mease, Joan T. Merrill, Robert G. Lahita, Mark J. Iannini, David E. Yocum, Ellen M. Ginzler, Robert S. Katz, Oscar S. Gluck, Mark C. Genovese, Ronald Van Vollenhoven, Kenneth C. Kalunian, Susan Manzi, Maria W. Greenwald, Jill P. Buyon, Nancy J. Olsen, Michael H. Schiff, Arthur F. Kavanaugh, Jacques R. Caldwell, Rosalind Ramsey-GoldmanE. William St. Clair, Allan L. Goldman, Rita M. Egan, Richard P. Polisson, Kevin G. Moder, Naomi F. Rothfield, Robert T. Spencer, Kathryn Hobbs, Barri J. Fessler, Leonard H. Calabrese, Larry W. Moreland, Stanley B. Cohen, Betty J. Quarles, Vibeke Strand, Marc Gurwith, Kenneth E. Schwartz

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus: Results of a multicenter randomized, double-blind, placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences